Skip to main content
Baycrest is a member of The Toronto Dementia Research Alliance, which was established by the Toronto Academic Health Science Network in 2009 as a new paradigm for collaborative research working to create an effective platform for consistent collection and interpretation of clinical data across member institutions. TDRA is working towards positioning itself as a Canadian research centre of excellence in dementia, co-morbidities and co-occurring contributory underlying disorders. The TDRA focuses on neurodegenerative diseases that result in clinical dementia, including Alzheimer’s disease, fronto-temporal degeneration, dementia with Lewy bodies, Parkinson’s disease dementia, and vascular cognitive impairment.